Soler D - Search Results

1

MLN3126, an antagonist of the chemokine receptor CCR9, ameliorates inflammation in a T cell mediated mouse colitis model.

Igaki K, Komoike Y, Nakamura Y, Watanabe T, Yamasaki M, Fleming P, Yang L, Soler D, Fedyk E, Tsuchimori N. Igaki K, et al. Among authors: soler d. Int Immunopharmacol. 2018 Jul;60:160-169. doi: 10.1016/j.intimp.2018.04.049. Epub 2018 May 4. Int Immunopharmacol. 2018. PMID: 29730559

2

The binding specificity and selective antagonism of vedolizumab, an anti-alpha4beta7 integrin therapeutic antibody in development for inflammatory bowel diseases.

Soler D, Chapman T, Yang LL, Wyant T, Egan R, Fedyk ER. Soler D, et al. J Pharmacol Exp Ther. 2009 Sep;330(3):864-75. doi: 10.1124/jpet.109.153973. Epub 2009 Jun 9. J Pharmacol Exp Ther. 2009. PMID: 19509315

3

CCR8 expression identifies CD4 memory T cells enriched for FOXP3+ regulatory and Th2 effector lymphocytes.

Soler D, Chapman TR, Poisson LR, Wang L, Cote-Sierra J, Ryan M, McDonald A, Badola S, Fedyk E, Coyle AJ, Hodge MR, Kolbeck R. Soler D, et al. J Immunol. 2006 Nov 15;177(10):6940-51. doi: 10.4049/jimmunol.177.10.6940. J Immunol. 2006. PMID: 17082609

4

Human G protein-coupled receptor GPR-9-6/CC chemokine receptor 9 is selectively expressed on intestinal homing T lymphocytes, mucosal lymphocytes, and thymocytes and is required for thymus-expressed chemokine-mediated chemotaxis.

Zabel BA, Agace WW, Campbell JJ, Heath HM, Parent D, Roberts AI, Ebert EC, Kassam N, Qin S, Zovko M, LaRosa GJ, Yang LL, Soler D, Butcher EC, Ponath PD, Parker CM, Andrew DP. Zabel BA, et al. Among authors: soler d. J Exp Med. 1999 Nov 1;190(9):1241-56. doi: 10.1084/jem.190.9.1241. J Exp Med. 1999. PMID: 10544196 Free PMC article.

5

CCR4 versus CCR10 in human cutaneous TH lymphocyte trafficking.

Soler D, Humphreys TL, Spinola SM, Campbell JJ. Soler D, et al. Blood. 2003 Mar 1;101(5):1677-82. doi: 10.1182/blood-2002-07-2348. Epub 2002 Oct 24. Blood. 2003. PMID: 12406880 Free article.

6

Lack of chemokine receptor CCR1 enhances Th1 responses and glomerular injury during nephrotoxic nephritis.

Topham PS, Csizmadia V, Soler D, Hines D, Gerard CJ, Salant DJ, Hancock WW. Topham PS, et al. Among authors: soler d. J Clin Invest. 1999 Dec;104(11):1549-57. doi: 10.1172/JCI7707. J Clin Invest. 1999. PMID: 10587518 Free PMC article.

7

PK1/EG-VEGF induces monocyte differentiation and activation.

Dorsch M, Qiu Y, Soler D, Frank N, Duong T, Goodearl A, O'Neil S, Lora J, Fraser CC. Dorsch M, et al. Among authors: soler d. J Leukoc Biol. 2005 Aug;78(2):426-34. doi: 10.1189/jlb.0205061. Epub 2005 May 20. J Leukoc Biol. 2005. PMID: 15908459

8

Beneficial effects of targeting CCR5 in allograft recipients.

Gao W, Faia KL, Csizmadia V, Smiley ST, Soler D, King JA, Danoff TM, Hancock WW. Gao W, et al. Among authors: soler d. Transplantation. 2001 Oct 15;72(7):1199-205. doi: 10.1097/00007890-200110150-00003. Transplantation. 2001. PMID: 11602842

9

Expression cloning of the STRL33/BONZO/TYMSTRligand reveals elements of CC, CXC, and CX3C chemokines.

Wilbanks A, Zondlo SC, Murphy K, Mak S, Soler D, Langdon P, Andrew DP, Wu L, Briskin M. Wilbanks A, et al. Among authors: soler d. J Immunol. 2001 Apr 15;166(8):5145-54. doi: 10.4049/jimmunol.166.8.5145. J Immunol. 2001. PMID: 11290797

10

Cellular assays of chemokine receptor activation.

Proudfoot AE, Power CA, Church DJ, Soler D, Mack M. Proudfoot AE, et al. Among authors: soler d. Curr Protoc Pharmacol. 2001 Nov;Chapter 12:Unit12.4. doi: 10.1002/0471141755.ph1204s14. Curr Protoc Pharmacol. 2001. PMID: 21959755

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

133 results

Search Page

Filters